VYNE Therapeutics Inc.

Report date
12/31/2022
Quarter
2022 Q4
Filed
2/15/2023
Shares
18,469
Value ($000)
3
Weight
0.0%
2021 Q1 - 2022 Q4 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).